Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate-gated chloride channels (GluCls) are ligand-gated ion channels found exclusively in protostome invertebrates, such as nematodes and arthropods. They are structurally related to mammalian glycine receptors but do not occur in vertebrates. Upon binding of glutamate, these channels open to allow chloride ions to flow across cell membranes, hyperpolarizing neurons or muscle cells and exerting inhibitory effects on neural circuits. GluCls are major targets of macrocyclic lactone anthelmintics (e.g., ivermectin), which lock the channel open, causing persistent inhibition that paralyzes and kills parasites.
Macrocyclic lactones bind to GluCls, locking the channel open, causing chloride influx, hyperpolarization, and paralysis of invertebrates.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-gated Chloride Channel (GluCl).